Authors:
HAYNES BP
GRIMSHAW RM
GRIGGS LJ
HARDCASTLE I
NUTLEY BP
JARMAN M
JOHNSTON SRD
TWELVES CJR
SOUKOP M
REA DW
HOWELL A
JONES A
COOMBES RC
Citation: Bp. Haynes et al., PHARMACOKINETIOS OF IDOXIFENE AND TAMOXIFEN IN A RANDOMIZED PHASE-II TRIAL IN BREAST-CANCER PATIENTS WHO HAVE RELAPSED ON TAMOXIFEN, Annals of oncology, 9, 1998, pp. 679-679
Authors:
BARRIE SE
HAYNES BP
POTTER GA
CHAN FCY
GODDARD PM
DOWSETT M
JARMAN M
Citation: Se. Barrie et al., BIOCHEMISTRY AND PHARMACOKINETICS OF POTENT NONSTEROIDAL CYTOCHROME P450(17-ALPHA) INHIBITORS, Journal of steroid biochemistry and molecular biology, 60(5-6), 1997, pp. 347-351
Authors:
JOHNSTON SRD
RIDDLER S
HAYNES BP
HERN RA
SMITH IE
JARMAN M
DOWSETT M
Citation: Srd. Johnston et al., THE NOVEL ANTIESTROGEN IDOXIFENE INHIBITS THE GROWTH OF HUMAN MCF-7 BREAST-CANCER XENOGRAFTS AND REDUCES THE FREQUENCY OF ACQUIRED ANTIESTROGEN RESISTANCE, British Journal of Cancer, 75(6), 1997, pp. 804-809
Authors:
SANDERS DA
HAYNES BP
TEWKESBURY GE
STOTT IJ
Citation: Da. Sanders et al., THE ADDITION OF NEURAL NETWORKS TO THE INNER FEEDBACK PATH IN ORDER TO IMPROVE ON THE USE OF PRE-TRAINED FEED FORWARD ESTIMATORS, Mathematics and computers in simulation, 41(5-6), 1996, pp. 461-472
Authors:
CHAN FCY
POTTER GA
BARRIE SE
HAYNES BP
ROWLANDS MG
HOUGHTON J
JARMAN M
Citation: Fcy. Chan et al., 3-PYRIDYLALKYL AND 4-PYRIDYLALKYL ADAMANTANECARBOXYLATES - INHIBITORSOF HUMAN CYTOCHROME P450(17-ALPHA) (17-ALPHA-HYDROXYLASE C-17,C-20-LYASE) - POTENTIAL NONSTEROIDAL AGENTS FOR THE TREATMENT OF PROSTATIC-CANCER/, Journal of medicinal chemistry, 39(17), 1996, pp. 3319-3323
Authors:
YOUNG H
CARNOCHAN P
TRIVEDI M
POTTER GA
ECCLES SA
HAYNES BP
JARMAN M
OTT RJ
Citation: H. Young et al., PHARMACOKINETICS AND BIODISTRIBUTION OF RADIOLABELED IDOXIFENE - PROSPECTS FOR THE USE OF PET IN THE EVALUATION OF A NOVEL ANTIESTROGEN FORCANCER-THERAPY, Nuclear medicine and biology, 22(4), 1995, pp. 405-411
Authors:
DOWSETT M
JOHNSTON SRD
HAYNES BP
SMITH IE
JARMAN M
Citation: M. Dowsett et al., IDOXIFENE DELAYS ACQUIRED ANTIESTROGEN RESISTANCE IN MCF-7 HUMAN BREAST-CANCER XENOGRAFTS, European journal of cancer, 31A, 1995, pp. 121-121
Authors:
COOMBES RC
HAYNES BP
DOWSETT M
QUIGLEY M
ENGLISH J
JUDSON IR
GRIGGS LJ
POTTER GA
MCCAGUE R
JARMAN M
Citation: Rc. Coombes et al., IDOXIFENE - REPORT OF A PHASE-I STUDY IN PATIENTS WITH METASTATIC BREAST-CANCER, Cancer research, 55(5), 1995, pp. 1070-1074
Authors:
BARRIE SE
POTTER GA
GODDARD PM
HAYNES BP
DOWSETT M
JARMAN M
Citation: Se. Barrie et al., PHARMACOLOGY OF NOVEL STEROIDAL INHIBITORS OF CYTOCHROME P450(17-ALPHA) (17-ALPHA-HYDROXYLASE C17-20 LYASE), Journal of steroid biochemistry and molecular biology, 50(5-6), 1994, pp. 267-273
Authors:
JOHNSTON SRD
HAYNES BP
SACKS NPM
MCKINNA JA
GRIGGS LJ
JARMAN M
BAUM M
SMITH IE
DOWSETT M
Citation: Srd. Johnston et al., EFFECT OF ESTROGEN-RECEPTOR STATUS AND TIME ON THE INTRA-TUMORAL ACCUMULATION OF TAMOXIFEN AND N-DESMETHYLTAMOXIFEN FOLLOWING SHORT-TERM THERAPY IN HUMAN PRIMARY BREAST-CANCER, Breast cancer research and treatment, 28(3), 1993, pp. 241-250
Authors:
JOHNSTON SRD
HAYNES BP
SMITH IE
JARMAN M
SACKS NPM
EBBS SR
DOWSETT M
Citation: Srd. Johnston et al., ACQUIRED TAMOXIFEN RESISTANCE IN HUMAN BREAST-CANCER AND REDUCED INTRA-TUMORAL DRUG CONCENTRATION, Lancet, 342(8886-7), 1993, pp. 1521-1522